Ben Sessa is a Somerset psychiatrist with a passion for getting psychedelics tested for medical purposes. He explains that the side effects of current antipsychotics can be off putting to people taking medication
The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews
Pharmaceutical cannabinoids such as nabiximols, nabilone and dronabinol, and plant-based cannabinoids have been investigated for their therapeutic potential in treating multiple sclerosis (MS) symptoms. This review of reviews aimed to synthesise findings from high quality systematic reviews that examined the safety and effectiveness of cannabinoids in multiple sclerosis. We examined the outcomes of disability and disability progression, pain, spasticity, bladder function, tremor/ataxia, quality of life and adverse effects.
Currently, anyone found in possession of cannabis can be sentenced to a maximum of five years in prison, an unlimited fine or both punishments under UK legislation
t may not be totally surprising then that recent research has highlighted how older people are turning to cannabis for pain relief as they develop age-related health problems – and for end-of-life care.
“If it’s heavily controlled by pharmaceutical companies it will be very expensive to buy. A way forward with this is difficult.”